Innovation in Women’s Cancer Accelerator Fund

• Applications open: 3 February 2025
• Applications close: 12 noon, 21 February 2025 

Projects must demonstrate: 

• Cross-sector, multidisciplinary collaboration, including at least one Welsh-based partner.
• Improved outcomes and experiences for women affected by cancer, aligning with Welsh policies.
• Value for money. 

Applicants must be:  

• Able to demonstrate that they have a UK-based bank account in the name of the lead applicant organisation
• Not in financial difficulties (able to pass due diligence checks on business status, and able to declare that the business and named applicants are not subject to any material litigation).
• Able to confirm that any insurance and compliance with legislated requirements are in place.
• Eligible to receive grant funding.
• Agree to monitoring and reporting requirements.
• Able to agree to sharing of high-level project details and outcomes in the public domain. 
• If the intended recipient is a non-public sector organisation and the intended mechanism of compliance with UK Subsidy  is through Minimal Financial Assistance (MFA) applicants must be eligible to receive grant funding (not have received £315,000 within the last three years) and provide a signed declaration to confirm. 
• Must be able to evidence expenditure on project activities and that required outcomes have been achieved.
• Costs to occur after the award letter date and before project activity deadline and related specifically to the project. 

Project teams or departments from within UK-registered organisations can apply for an award between £5,000 to £10,000. 

• Applicants should complete the Innovation in Women’s Cancer Accelerator Fund Application Form and return to hello@lshubwales.com with the required supporting information before 21 February 2025.
• An assessment panel will be convened following the closing date. 
• Applications will be assessed by the appointed panel and a scoring system will be used to determine successful awardees 
• The assessment panel’s decision will be communicated to applicants by official letter. Payment of grant funding to successful applicants will be subject to a signed collaboration agreement (contract) covering the work. 

Important: You should not commence any project work until you have received written confirmation of your successful application. Starting work before a signed collaboration agreement is in place between Life Sciences Hub Wales and the beneficiary organisation is done at your own risk. 

Successful applicants will be required to sign a Life Sciences Hub Wales collaboration agreement which sets out the terms and conditions of the grant, including: 

• The amount to be awarded
• Deadlines by which the money should be spent
• Monitoring requirements